| Home > Articles > Published articles > Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis |
| Date: | 2024 |
| Abstract: | Background and objective: Between 5% and 10% of amyotrophic lateral sclerosis (ALS) cases have a family history of the disease, 30% of which do not have an identifiable underlying genetic cause after a comprehensive study of the known ALS-related genes. Based on a significantly increased incidence of ALS in a small geographical region from Spain, the aim of this work was to identify novel ALS-related genes in ALS cases with negative genetic testing. Methods: We detected an increased incidence of both sporadic and, especially, familial ALS cases in a small region from Spain compared with available demographic and epidemiological data. We performed whole genome sequencing in a group of 12 patients with ALS (5 of them familial) from this unique area. We expanded the study to include affected family members and additional cases from a wider surrounding region. Results: We identified a shared missense mutation (c. 1586C. |
| Grants: | Instituto de Salud Carlos III PI19/01543 Instituto de Salud Carlos III PI23/00845 Instituto de Salud Carlos III PI18/00326 Instituto de Salud Carlos III PI21/01395 Instituto de Salud Carlos III PI21/00791 |
| Rights: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. |
| Language: | Anglès |
| Document: | Article ; recerca ; Versió publicada |
| Published in: | Journal of Neurology, Neurosurgery, and Psychiatry, (july 2024) , ISSN 1468-330X |
8 p, 1.1 MB |